FDA stem cells
This is an old revision of this page, as edited by Aschlafly (talk | contribs) at 02:45, July 13, 2023. It may differ significantly from current revision.
FDA stem cell court cases total 215, of which 178 are federal court decisions concerning the FDA and stem cells. Of these, the FDA was a party in
Generally the FDA attempts to block and impede the use of adult stems cells as much as the FDA possibly can, and often beyond what Congress has authorized the FDA to do.
Analogous therapies
The Fifth Circuit found that "extracellular vesicle ("EV") [is a] product similar to stem cell therapy." Direct Biologics, L.L.C. v. McQueen, 63 F.4th 1015, 1017 (5th Cir. 2023) (deciding a trade secret-related issue.